Loading…
Kor-Chem, Inc. was cited for significant Current Good Manufacturing Practice (CGMP) violations in the production of over-the-counter hand sanitizer drug products at its Atlanta facility. The FDA found that the company failed to establish and follow adequate written procedures for cleaning and maintenance of shared manufacturing equipment, which was also used to produce industrial chemical products bearing hazard warnings for corrosivity and severe burns. The inspection documented that equipment usage logs lacked documentation of proper cleaning between batches of hazardous industrial chemicals and subsequent drug product manufacturing, creating potential cross-contamination risks. The company had discontinued its drug products and indicated it was developing a remedial plan, but had not provided the FDA with detailed corrective action responses to the inspection observations at the time the warning letter was issued.